Amit Majithia

Amit Majithia

The federal funding disruptions forced abrupt changes in multiple research programs, particularly those involving long-term global health partnerships and human subject research.

For Amit Majithia, MD, associate professor of medicine, the pivot grant provided time and resources to protect and expand his research on insulin resistance and why some people progress to disease while others do not.

“Through human genetics, blood-based proteomics, and adipose tissue biology, our goal is to identify genes and circulating proteins that can serve as biomarkers, therapeutic targets, or better ways to classify risk,” said Majithia.

His project grew out of earlier work on sex differences in cardiometabolic disease. Before menopause, women tend to have some protection against insulin resistance-related conditions, but that protection declines post-menopause. That research identified factors released by fat tissue that may contribute to insulin resistance and cardiovascular disease, including a gene called TNFAIP8.

The pivot grant allowed the lab to expand the scope of the research beyond sex-specific questions and generate new preliminary data for future funding opportunities, including programs focused on diseases affecting women veterans.

“The pivot grant allowed us to broaden the work,” Majithia said. “We are now studying which proteins secreted by human fat cells may play a causal role in diabetes and cardiovascular disease across broader populations.”

In practical terms, the grant helped convert a federal funding disruption from a hard stop into a scientific pivot. “It allowed us to move from a cancelled grant application to a broader, fundable research program,” he added.